Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD, USA.
PPS, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Am J Drug Alcohol Abuse. 2022 May 4;48(3):338-346. doi: 10.1080/00952990.2022.2033758. Epub 2022 Apr 25.
Maryland expanded its "Statewide Naloxone Standing Order" (NSO) in 2017 to eliminate training and prescription requirements for obtaining naloxone, improve naloxone access, help reverse opioid overdose, and reduce overdose fatality rates. To assess the change in the trends of fatal opioid overdose rates following the expansion of the Naloxone Standing Order (eNSO) and its association with the social determinants of health (SDoH). Data on overdose deaths and SDoH from 2015-2019 was collected and analyzed using interrupted time series and multivariate Poisson regression models to study the change in trends and the associations. There was a significant decrease in the rate of fatal overdoses after the intervention: prescription opioid estimate number of deaths declined by .25 per 100,000 ( = .02), heroin estimate number of deaths declined by 1.83 per 100,000 ( < .001), fentanyl estimate number of deaths declined by 2.54 per 100,000 ( < .001). After controlling for eNOS implementation in Maryland, state-level estimates with high proportions of female residents and those with bachelor's degree or higher were associated with reduction in overdose, while state-level estimates with high proportions of African Americans and higher employment rates were associated with an increase in overdose. Our analysis shows that the expanded naloxone standing order is associated with reducing opioid-related overdose death rates. Even though we observed a significant reduction in overdose death rate in fentanyl-related deaths, the rate of deaths post-eNSO was still increasing, suggesting the need for additional measures to impact the rates of fentanyl.
马里兰州于 2017 年扩大了其“全州纳洛酮常备令”(NSO),取消了获取纳洛酮的培训和处方要求,以改善纳洛酮的可及性,帮助逆转阿片类药物过量,并降低过量死亡率。为了评估在扩大纳洛酮常备令(eNSO)后,致命阿片类药物过量率的趋势变化及其与健康社会决定因素(SDoH)的关联。从 2015 年至 2019 年收集了有关过量死亡和 SDoH 的数据,并使用中断时间序列和多变量泊松回归模型进行分析,以研究趋势的变化及其关联。干预后致命性过量的发生率显着下降:处方类阿片估计死亡人数减少了 25 人/每 10 万人( = 0.02),海洛因估计死亡人数减少了 183 人/每 10 万人(<0.001),芬太尼估计死亡人数减少了 254 人/每 10 万人(<0.001)。在控制马里兰州 eNOS 实施情况后,居民中女性比例较高和拥有学士或更高学位的州级估计值与减少过量有关,而居民中非洲裔美国人比例较高和就业率较高的州级估计值与过量增加有关。我们的分析表明,扩大纳洛酮常备令与降低阿片类药物相关的过量死亡有关。尽管我们观察到与芬太尼相关的过量死亡人数显著减少,但 eNSO 后死亡人数仍在增加,这表明需要采取额外措施来影响芬太尼的死亡率。